- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/033 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
Patent holdings for IPC class C07D 295/033
Total number of patents in this class: 72
10-year publication summary
|
10
|
3
|
7
|
7
|
7
|
6
|
5
|
7
|
8
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Omeros Corporation | 307 |
3 |
| H. Lundbeck A/S | 1228 |
3 |
| Daegu-gyeongbuk Medical Innovation Foundation | 106 |
3 |
| The Trustees of the University of Pennsylvania | 4315 |
2 |
| Chemo Research, S.L. | 100 |
2 |
| Crystal Pharma, S.A.U. | 50 |
2 |
| Infineum International Limited | 383 |
2 |
| Qatar University | 178 |
2 |
| Sage Therapeutics, Inc. | 362 |
2 |
| SK Biopharmaceuticals Co., Ltd. | 261 |
2 |
| Glaxo Group Limited | 4131 |
1 |
| Bristol-myers Squibb Company | 4875 |
1 |
| BASF SE | 20803 |
1 |
| LG Chem, Ltd. | 17564 |
1 |
| The Regents of the University of California | 19839 |
1 |
| Bayer Pharma AG | 1061 |
1 |
| FUJIFILM Corporation | 29251 |
1 |
| DSM IP Assets B.V. | 5603 |
1 |
| Abbvie Inc. | 1803 |
1 |
| Japan Science and Technology Agency | 1339 |
1 |
| Other owners | 39 |